
浏览全部资源
扫码关注微信
1.中山市第二人民医院,广东 中山 528447
2.广东药科大学公共卫生学院,广州 510006
3.中山市港口医院药剂科,广东 中山 528447
主任药师,硕士。研究方向:临床药物依赖、医院制剂。E-mail:moguodong2002@163.com
教授,硕士生导师。研究方向:公共卫生。E-mail:gdwangbaoguo@163.com
收稿:2025-09-16,
修回:2025-10-15,
录用:2025-12-31,
纸质出版:2026-01-30
移动端阅览
莫国栋,林悦,陈英辉,等.美沙酮维持治疗患者成功戒断的影响因素分析[J].中国药房,2026,37(02):210-214.
MO Guodong,LIN Yue,CHEN Yinghui,et al.Analysis of influencing factors for successful detoxification in patients undergoing methadone maintenance therapy[J].ZHONGGUO YAOFANG,2026,37(02):210-214.
莫国栋,林悦,陈英辉,等.美沙酮维持治疗患者成功戒断的影响因素分析[J].中国药房,2026,37(02):210-214. DOI: 10.6039/j.issn.1001-0408.2026.02.13.
MO Guodong,LIN Yue,CHEN Yinghui,et al.Analysis of influencing factors for successful detoxification in patients undergoing methadone maintenance therapy[J].ZHONGGUO YAOFANG,2026,37(02):210-214. DOI: 10.6039/j.issn.1001-0408.2026.02.13.
目的
2
探讨美沙酮维持治疗患者成功戒断的影响因素。
方法
2
回顾性选择2012年1月1日至2025年1月1日在中山市第二人民医院南区分院(包括中山市石岐区、西区、开发区等美沙酮维持治疗服药点)收治的161例美沙酮维持治疗患者为研究对象。收集患者的社会人口学信息、毒品滥用史、实验室检测结果、用药记录等。根据美沙酮是否被成功戒断将患者分为未成功戒断组和成功戒断组,采用单因素、单因素Cox回归和多因素Cox比例风险回归进行影响因素分析,并采用Kaplan-Meier法进行生存分析。
结果
2
161例患者中,成功戒断组有96例,未成功戒断组有65例,成功戒断率为59.63%。多因素Cox比例风险回归分析结果显示,年龄、户籍地、第一次吸毒年龄、吸毒年限对美沙酮维持治疗患者成功戒断均有显著影响(
P
<0.05)。其中,中山市本地户籍患者的成功戒断率是外市户籍的8.364倍;患者年龄每增加1岁,成功戒断率降低22.7%;第一次吸毒年龄每增加1年,成功戒断率上升33.4%;吸毒年限每增加1年,成功戒断率增加33.5%。生存分析结果显示,美沙酮末次服用低剂量组(≤30.8 mg)患者的成功戒断率显著高于美沙酮末次服用高剂量组(>30.8 mg)患者(
P
=0.015),中山市本地户籍人群的成功戒断率显著高于外市户籍人群(
P
<0.001)。
结论
2
年龄、户籍地、第一次吸毒年龄、吸毒年限是美沙酮维持治疗患者成功戒断的独立影响因素,而美沙酮末次服用剂量可能与成功戒断相关。
OBJECTIVE
2
To explore the influencing factors for successful detoxification in patients undergoing methadone maintenance therapy.
METHODS
2
A retrospective selection of 161 methadone maintenance therapy patients from the South Branch of Zhongshan Second People’s Hospital (including methadone maintenance treatment sites in Shiqi District, Xiqu District, Development Zone of Zhongshan City) from January 1, 2012, to January 1, 2025, was conducted as the study object. Data collected included patients’ sociodemographic information, drug abuse history, laboratory test results, medication records, etc. Patients were divided into the unsuccessful detoxification group and the successful detoxification group based on whether methadone detoxification was achieved. Univariate, univariate Cox regression, and multivariate Cox proportional hazards regression were used for influencing factor analysis, and the Kaplan-Meier method was employed for survival analysis.
RESULTS
2
Among the 161 methadone maintenance therapy patients, 96 were in the successful
detoxification group and 65 in the unsuccessful detoxification group, yielding a successful detoxification rate of 59.63%. Multivariate Cox proportional hazards regression analysis revealed that age, registered residence status, age at first drug use, and duration of drug abuse were key influencing factors for successful detoxification in methadone maintenance therapy patients (
P
<0.05). Specifically, the successful detoxification rate for patients with Zhongshan local registered residence was 8.364 times higher than that for patients with non-local registered residence; for every 1-year increase in patient age, the successful detoxification rate decreased by 22.7%; for every 1-year increase in age at first drug use, the successful detoxification rate rose by 33.4%; and for every 1-year increase in duration of drug abuse, the successful detoxification rate increased by 33.5%. Survival analysis showed that the successful detoxification rate in the methadone low-dose group (≤30.8 mg) was significantly higher than that in the methadone high-dose group (>30.8 mg) (
P
=0.015), and the successful detoxification rate in the population with Zhongshan local registered residence was significantly higher than that in those with non-local registered residence (
P
<0.001).
CONCLUSIONS
2
Age, registered residence status, age at first drug use, and duration of drug abuse are key influencing factors for successful detoxification in patients undergoing methadone maintenance therapy, and the last methadone dose may be associated with successful detoxification.
FRIEBEL R , YOO K J , MAYNOU L . Opioid abuse and austerity:evidence on health service use and mortality in England [J ] . Soc Sci Med , 2022 , 298 : 114511 .
杨瑾 , 莫国栋 , 李晓东 , 等 . 盐酸纳曲酮植入剂在阿片类药物使用障碍患者中的研究进展 [J ] . 中国处方药 , 2025 , 23 ( 16 ): 109 - 113 .
唐仁海 , 吴婧 , 叶润华 , 等 . 2016年云南省德宏州美沙酮维持治疗者服药依从性影响因素 [J ] . 中国艾滋病性病 , 2019 , 25 ( 4 ): 395 - 398 .
KREUTZWISER D , TAWFIC Q A . Methadone for pain management:a pharmacotherapeutic review [J ] . CNS Drugs , 2020 , 34 ( 8 ): 827 - 839 .
LI M D , HSER Y I , CHEN Z W , et al . Promoting global health:prevention and treatment of substance abuse and HIV in Asia [J ] . J Neuroimmune Pharmacol , 2016 , 11 ( 3 ): 379 - 382 .
曹晓斌 , 吴尊友 . 美沙酮维持治疗预防HIV研究进展 [J ] . 中国艾滋病性病 , 2011 , 17 ( 2 ): 196 - 199 .
ZHOU K N , ZHUANG G H . Retention in methadone maintenance treatment in China’s mainland,2004-2012:a literature review [J ] . Addict Behav , 2014 , 39 ( 1 ): 22 - 29 .
张帅 . 美沙酮维持治疗患者戒断症状、情绪状态及生活质量的随访研究 [D ] . 广州 : 广州医科大学 , 2023 .
林毅翔 , 谢剑锋 , 邱月锋 , 等 . 美沙酮维持治疗患者复吸毒品风险预测:基于lasso-Logistic模型分析的回顾性队列研究 [J ] . 中国公共卫生 , 2025 , 41 ( 12 ): 1481 - 1487 .
陈君 , 陈雯 , 凌莉 , 等 . 广东省社区美沙酮维持治疗剂量使用现状及其评价 [J ] . 现代预防医学 , 2010 , 37 ( 9 ): 1687 - 1689 .
AMATO L , DAVOLI M , MINOZZI S , et al . Methadone at tapered doses for the management of opioid withdrawal [J ] . Cochrane DB Syst Rev , 2013 , 2013 ( 2 ): CD003409 .
ZHANG L , CHOW E P F , ZHUANG X , et al . Methadone maintenance treatment participant retention and behav-ioural effectiveness in China:a systematic review and meta-analysis [J ] . PLoS One , 2013 , 8 ( 7 ): e68906 .
张雍 , 李革 , 彭传轮 , 等 . 影响重庆市海洛因成瘾者美沙酮维持治疗保持和脱失因素研究 [J ] . 中国药物依赖性杂志 , 2009 , 18 ( 5 ): 433 - 437 .
杨跃诚 , 段松 , 项丽芬 , 等 . 云南省德宏州海洛因成瘾者美沙酮维持治疗保持率及其影响因素 [J ] . 中华流行病学杂志 , 2011 ,( 2 ): 125 - 129 .
马桂林 , 张婉君 , 张建梅 , 等 . 厦门市美沙酮维持治疗门诊HIV感染者治疗与随访情况分析 [J ] . 中国药物滥用防治杂志 , 2024 , 30 ( 11 ): 1976 - 1979 .
林毅翔 , 吴韶彬 , 谢剑锋 . 福建省美沙酮维持治疗患者脱失情况及影响因素 [J ] . 中国艾滋病性病 , 2023 , 29 ( 12 ): 1348 - 1351 .
陈勋 , 胡荣 , 胡雪娇 , 等 . 武汉市美沙酮维持治疗者孤独感与毒品使用的关系研究 [J ] . 转化医学杂志 , 2025 , 14 ( 8 ): 155 - 159 .
田飞 , 刘国武 , 马文立 , 等 . 2006—2020年北京市东城区美沙酮维持治疗患者依从性及影响因素分析 [J ] . 实用预防医学 , 2022 , 29 ( 5 ): 532 - 535 .
刘雪娇 . 美沙酮维持治疗患者复吸风险评估工具的研发 [D ] . 北京 : 中国疾病预防控制中心 , 2021 .
盛鑫 . 美沙酮维持治疗患者社会支持、应对方式及冲动性相关因素研究 [D ] . 芜湖 : 皖南医学院 , 2019 .
戴明妹 . 江苏省部分地区美沙酮维持治疗者脱失现状及影响因素研究 [D ] . 北京 : 中国疾病预防控制中心 , 2018 .
吴韶彬 , 林毅翔 , 张明雅 , 等 . 2006—2024年福建省美沙酮维持治疗患者退出状况及影响因素研究 [J ] . 中国预防医学杂志 , 2025 , 26 ( 9 ): 1090 - 1095 .
赖文胜 . 美沙酮门诊入组治疗患者首剂量引入与调整 [J ] . 中国药物依赖性杂志 , 2008 , 17 ( 3 ): 201 - 203 .
0
浏览量
31
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621